InnoCare Pharma (SEHK:9969) Achieves Key Milestone With ICP-488 Phase II Success in Psoriasis Treatment

Yahoo FinanceNov 2 20:40 ET

Innocare (09969.HK) plans to hold a board of directors meeting on November 11 to approve the third quarter performance.

Gloryhui October 28th | innocare (09969.HK) announced that the board of directors will hold a meeting on November 11, 2024 (Monday) to consider and approve the unaudited third quarter performance of the company and its subsidiaries for the nine months ending September 30, 2024, as well as its release.

Gelonghui FinanceOct 28 04:32 ET

INNOCARE: DATE OF BOARD MEETING

HKEXOct 28 04:30 ET · Announcements

Jefferies Sticks to Its Buy Rating for InnoCare Pharma Ltd. (9969)

TipRanksOct 27 08:15 ET · Ratings

Is InnoCare Pharma (HKG:9969) Using Too Much Debt?

Simply Wall StOct 24 03:36 ET

HK stock market anomaly | Most pharmaceutical stocks are strong, with a number of bullish policies coming out successively this year, which is expected to promote the long-term increase in trading volume of innovative drugs in the country.

Most pharmaceutical stocks are performing well, as of the time of publication, Lai Kai zai lab-B (02105) rose by 12.27%, closing at 8.05 Hong Kong dollars; zai lab (09688) rose by 11.72%, closing at 22.4 Hong Kong dollars; Ho Yu-B (02256) rose by 9.6%, closing at 3.88 Hong Kong dollars.

Zhitong FinanceOct 17 22:57 ET